Navigation Links
New Effort to Battle Antibiotic Resistance Rallies Researchers Throughout Harvard University
Date:10/13/2009

BOSTON, Oct. 13 /PRNewswire/ -- The National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) have awarded $5 million to an interdisciplinary group of Harvard researchers to launch the "Harvard-wide Program on Antibiotic Resistance." Headed by Michael S. Gilmore, Ph.D., (Senior Scientist, Schepens Eye Research Institute and Schepens Professor of Ophthalmology [Department of Microbiology and Molecular Genetics], HMS), the group is uniting Harvard institutions in the fight against methicillin-resistant Staphylococcus aureus (MRSA) and other antibiotic resistant infection. The goal of the project is for the research team with a range of expertise to tackle the problem from different directions, and then to translate those findings into better treatments.

It shocked many a year and a half ago when CDC researchers noted that methicillin-resistant S. aureus (MRSA) were killing more in the US than HIV/AIDS (over 18,000 deaths per year). According to Gilmore, other penicillin resistant strains of S. aureus cause almost half again as many deaths. Worse, since 2002, MRSA have been acquiring resistance to one of the last line drugs used to treat those infections, vancomycin, a problem he has been studying with scientists at CDC.

MRSA are a major concern for hospitalized patients. More recently they have begun causing infections in healthy individuals in the community as well -- approximately 15% of invasive MRSA infections occur in patients with no known underlying cause. Most of these infections begin as skin infections, some acquired in sports locker rooms and other shared facilities. The infections become life-threatening when the microbe enters the bloodstream. New strains of MRSA have emerged that are causing many of the community infections.

Gilmore credits the Harvard-wide Microbial Sciences Initiative (an initiative launched in 2004 to bring
'/>"/>

SOURCE Schepens Eye Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts
2. Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts
3. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
4. Nationwide Progress Poll Reveals Increased Efforts by Hospitals to Control MRSA Infection
5. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
6. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
7. U.S. Naval Medical Research Center Resubmits IND Application for Proposed Op RESUS Clinical Trial in Trauma Patients in the Battlefield Setting
8. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
9. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
10. Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup
11. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... FT LAUDERDALE, Florida , July 1, 2015 /PRNewswire/ ... manufacturer and marketer of innovative medical devices for the treatment ... it prevailed in a final opposition appeal hearing in the ... 482 - STENT HAVING HELICAL ELEMENTS (,482). The ,482 patent ... and has been upheld as a valid patent in amended ...
(Date:7/1/2015)... 1, 2015 Qiming Venture Partners, today announces ... Partner effective immediately. William has been with ... participated in many Qiming healthcare deals, and assisted many ... market. Qiming, s success in healthcare is not a ... himself with his outstanding advocacy and service mentality on ...
(Date:7/1/2015)... , June 24, 2015 ... the addition of the "Future Horizons and ... 2015: Supplier Shares and Country Forecasts" report ... Growth Strategies in the European Blood Banking Market ... order to help current suppliers and potential market ...
Breaking Medicine Technology:OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2Qiming Announces the Promotion of William Hu to Managing Partner 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3
... Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), ... Data Safety Monitoring Board (DSMB) recently completed a ... Soligenix,s confirmatory Phase 3 clinical trial of orBec® ... acute gastrointestinal Graft-versus-Host disease (GI GVHD). ...
... CHAPEL HILL, N.C., Sept. 15, 2011 Cempra ... clinical trial investigating the efficacy, safety and tolerability ... solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with ... pneumonia (CABP).  In the Phase II trial, CEM-101 ...
Cached Medicine Technology:Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 2Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 4Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 5Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 6Cempra Announces Comparable Efficacy of Oral Solithromycin (CEM-101) Compared with Levofloxacin in Phase II Clinical Trial in Patients with Community-Acquired Bacterial Pneumonia (CABP) 2Cempra Announces Comparable Efficacy of Oral Solithromycin (CEM-101) Compared with Levofloxacin in Phase II Clinical Trial in Patients with Community-Acquired Bacterial Pneumonia (CABP) 3
(Date:7/1/2015)... ... 2015 , ... Sir Fazle Hasan Abed, BRAC’s founder and chairperson, was announced ... been recognised for his outstanding contribution to enhancing the world's production and distribution of ... World Food Prize Foundation, announced this year’s winner at a ceremony at the State ...
(Date:7/1/2015)... ... July 01, 2015 , ... SuiteRx, innovative ... combo, and compounding pharmacy operations, announces the most recent positioning of SuiteRx CEO, ... RBC event at the Venetian Las Vegas, Nevada. During this event, ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and Families ... Trust. The grant will allow CCF to improve quality of care and save costs ... formed to respond to many changes in New York’s Medicaid system. Experts agree that ...
(Date:7/1/2015)... ... July 01, 2015 , ... Did you know that infertility ... Health Month, and we at Advanced Fertility Center of Texas (AFCT) would like to ... , While infertility is often considered to be a “woman’s issue,” male fertility factors ...
(Date:7/1/2015)... ... July 01, 2015 , ... “Well-meaning ... Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... years who participated in the National Survey on Drug Use and Health, which ...
Breaking Medicine News(10 mins):Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2
... 28 The one-stop marketplace,for the fine and ... take place at SETEC in Seoul, South Korea, ... range of items in these fields, from,ingredients and ... http://www.newscom.com/cgi-bin/prnh/20080728/NYM070 ), Since its launch ...
... Safety Violations, SALINAS, Calif., July 28 Nursing ... Care Center will,hold a joint demonstration Tuesday asking their ... both of these homes made Windsor,owners over $2 million ... eight Bay Area nursing homes operated by Windsor,Healthcare., ...
... millions of Mexican pesos as of December,31, 2007. Comparisons are ... may vary due to rounding practices. "bp" stands,for basis points), ... - Gross income increased 34.45%, - Gross margin ... as a percentage of sales were 7.19%, - The ...
... Isn,t it odd that cancer cells from one organ, such ... totally different organ, like the lung? , What,s more, why ... to certain places? Prostate cancer usually moves to bone; colon ... Hendrik van Deventer, assistant professor of medicine at the University ...
... Laboratories to Improve ... to Care Across the Country, DAR ES SALAAM, Tanzania, July ... Welfare, United Republic,of Tanzania, and Abbott Fund commemorated the latest step ... cornerstone,for the first of 23 hospital laboratories to be built or ...
... Healthcare, Inc.,(OTC Bulletin Board: TONJ), a premier provider ... it has engaged German,based Dr. Petri Hospital Consulting ... in Nanning, China., Previously, the company reported ... now readjusted architectural and operational plans to,incorporate additional ...
Cached Medicine News:Health News:Most Influential Events for Korea's Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November 2Health News:Most Influential Events for Korea's Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November 3Health News:Most Influential Events for Korea's Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November 4Health News:Caregivers at 8 Bay Area Nursing Homes Protest Unsafe Resident Conditions in Salinas 2Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 2Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 3Health News:Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively 4Health News:Study provides clues to preventing and treating cancer spread 2Health News:Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System 2Health News:Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System 3Health News:Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System 4Health News:Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System 5Health News:Tongji Hires German Based Dr. Petri Consulting GmbH for Langdong Project 2
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
For the quantitative in vitro determination of creatinine in serum, plasma or urine....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
Medicine Products: